Gilead Raday, Chief Operating Officer at RedHill Biopharma, sold RDHL on Oct 1, 2026
Data as of Oct 16
▼ SELL$1.4K14,310,000 shares at $0.00Gilead Raday Chief Operating OfficerRDHL RedHill Biopharma Ltd.
- Traded
- Oct 1, 2026
- Disclosed
- Oct 6, 2026
- Filed
- 5 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RDHL since disclosure
−0.8%
after the sale
Similar stocks (SPY) since disclosure
−2.0%
S&P 500 (SPY)
Change in closing price from Oct 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.